Professional Documents
Culture Documents
Finaccurate Advisory Presentation
Finaccurate Advisory Presentation
Finaccurate Advisory Presentation
OVERVIEW
Finaccurate Investments is a Real Estate & Private Equity investment vehicule created by serial entrepreneurs with strong
track records to generate agressive investment return
70% Real Estate 30% Private equity with Industry Focus: Various
Investment focus
Minority/Majority stake in early or late stage of high disruptive models
Real Estate mainly in Monaco and projects with high rentability rate.
Investment Criteria Companies with high technology leadership, proven business model and
strong capability of the management. Average position: 0.5 up to 3m€ (+
a further reserve up to 3m€ to sustain the growth).
Legal form Luxemburg domiciled SCA (société en commandite par actions) including 3
pockets shares : A1 (normal share), A2 (Real Estate only), A3 (Private Equity only)
Currency EUR
Redemption Possible as soon as the Real Estate project is closed (around 3 years
so autumn 2020)
Valuation frequency On a quarterly basis starting autumn 2020, semi annually before.
Asset Allocation 70% in Monaco Real Estate project resulting in a 50 to 70m€ net profit
result in 3 to max years. Proceeds (between 126 and 140m€ will be
invested into AAA debt instruments to provide our company with liquidity
and non-risky investment.
➢ You believe that combined expertise from investors and fund management team can bring value to
➢ You are looking for higher return and liquidity offer (as soon as 3 years from investment start)
➢ You want to be part of the investment decision making process and propose your own investment ideas ?
➢ You expect the fund management team to invest as well and be committed ?
➢ You are looking for full transparency in the costs and returns ?
➢ Real Estate projects : Buildings around Geneva, Offices in Paris, ongoing projects in Nice and Monaco area,
➢ FinTech : Actio-Finance, Amfine services & software, Evidency, Fortia, Legtech, Traderforce, Oxial
First successful Trackrecord built in the last 10 years with seed money
Our investment methodology process
Advisors team :
MF: Real Estate company CEO in Monaco, 25 years experience, solid track record in Real Estate projects management.
DL: Senior Banker, Stock Exchange General Director, Investment Advisor.
MA: 40 years experience as a senior banker in France, US, HK for leading banking institutions.
JCB: IT Engineer, Successful entrepreneur in FinTech, Buildings & Private equity investments.
SC: Family Office Partner.
CD: Polytechnique school, Trader in US Bank, Market leader of rare spirits trading.
PG: IT Engineer, Successful entrepreneur in FinTech, Buildings projects & Private equity investments.
GP: serial entrepreneur with 40 years successful track-record.
AB: Business Lawyer, Law firm partner and founder.
OG: Private Banker, Fund Manager, Private Equity Advisor.
SCA in Luxembourg
Finaccurate Advisory
« Commandité » Common Pockets
C shares and P1, P2,…shares
Investments
Our governance
Advise
requests
Checking
3. Compliance and final steps documents by
Execution
Finaccurate &
Yes
Experts
Our Investment strategy
Sourcing
Man team Networks
Hands-on Investment Management
stake > €0,5 m to €4m < in innovative Exit
Coporate & legal assistance
companies Find exit options
Go to Market strategy (Marketing, business
Shareholders agreement Align Fund’s interest with management’s one
development and sales )
Low entry valuation compared to VC to fix the exit strategy.
Operational expertise
benchmarks Deal & execute
International strategy
Exit possibility
6 Builing project in French Riviera deal negociation 86/100 2 000 000 € 100% 15/12/2017 2 3 500 000 € 3 500 000 € 75% 38% 3 078 000 € 54% 27%
prototype
7 Green Technology company development 74/100 4 000 000 € 35% 15/10/2017 5 20 000 000 € 7 000 000 € 75% 15% 7 018 172 € 75% 15%
8 Data security Biz development 85/100 5 000 000 € 10% 15/10/2017 4 150 000 000 € 15 000 000 € 200% 50% 12 098 013 € 142% 35%
9 New cleantech painting Biz development 79/100 4 000 000 € 15% 15/10/2017 4 90 000 000 € 13 500 000 € 238% 59% 10 578 410 € 164% 41%
10 Medical new technology pre-industrialization 76/100 1 000 000 € 25% 15/10/2017 4 10 000 000 € 2 500 000 € 150% 38% 2 119 603 € 112% 28%
Total & Average 30 000 000 € 05/11/2017 4,10 128 166 667 € 427% 104% 537 869 095 € 242% 59%
We expect to invest 100m€ and target 30% net return per annum
Contact: Michael Priem, mpriem@finaccurate.fr – 06 63 28 89 60